222
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Driving risks of young drivers with symptoms of attention deficit hyperactivity disorder: association with the dopamine transporter gene VNTR polymorphism

, , &
Pages 575-583 | Received 28 Sep 2021, Accepted 17 Jan 2022, Published online: 07 Feb 2022

References

  • World Health Organization. Global status report on road safety 2018: Summary. (No. WHO/NMH/NVI/18.20). Geneva:World Health Organization; 2018.
  • Burtăverde V, Chraif M, Aniţei M, et al. The HEXACO model of personality and risky driving behavior. Psychol Rep. 2017;120(2):255–270.
  • McCartt AT, Shabanova VI, Leaf WA. Driving experience, crashes and traffic citations of teenage beginning drivers. Accid Anal Prev. 2003;35(3):311–320.
  • Paaver M, Eensoo D, Pulver A, et al. Adaptive and maladaptive impulsivity, platelet monoamine oxidase (MAO) activity and risk-admitting in different types of risky drivers. Psychopharmacol (Berl). 2006;186(1):32–40.
  • Regev S, Rolison JJ, Moutari S. Crash risk by driver age, gender, and time of day using a new exposure methodology. J Safety Res. 2018;66:131–140.
  • Barkley RA, Guevremont DC, Anastopoulos AD, et al. Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3-to 5-year follow-up survey. Pediatrics. 1993;92(2):212–218.
  • Barkley RA, Murphy KR, Dupaul GJ, et al. Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning. J Int Neuropsychol Soc. 2002;8(5):655–672.
  • Brunkhorst-Kanaan N, Libutzki B, Reif A, et al. ADHD and accidents over the life span – a systematic review. Neurosci Biobehav Rev. 2021;125:582–591.
  • Fried R, Petty CR, Surman CB, et al. Characterizing impaired driving in adults with attention-deficit/hyperactivity disorder: a controlled study. J Clin Psychiatry. 2006;67(04):567–574.
  • Kittel-Schneider S, Wolff S, Queiser K, et al. Prevalence of ADHD in accident victims: results of the PRADA study. J Clin Med. 2019;8(10):1643–1656.
  • Vaa T. ADHD and relative risk of accidents in road traffic: a meta-analysis. Accid Anal Prev. 2014;62:415–425.
  • Buitelaar, J. K., Kan, C. C., & Asherson, P. (eds.). ADHD in adults: characterization, diagnosis, and treatment. New York: Cambridge University Press; 2011.
  • King S, Waschbusch DA. Aggression in children with attention-deficit/hyperactivity disorder. Expert Rev Neurother. 2010;10(10):1581–1594.
  • Ramirez CA, Rosén LA, Deffenbacher JL, et al. Anger and anger expression in adults with high ADHD symptoms. J Atten Disord. 1997;2(2):115–128.
  • Mulligan A, Anney RJL, O’Regan M, et al. Autism symptoms in attention-deficit/hyperactivity disorder: a familial trait which correlates with conduct, oppositional defiant, language and motor disorders. J Autism Dev Disord. 2009;39(2):197–209.
  • Faraone SV, Larsson H. Genetics of attention deficit hyperactivity disorder. Mol Psychiatry. 2019;24(4):562–575.
  • Demontis D, Walters RK, Martin J, et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat Genet. 2019;51(1):63–75.
  • Larsson H, Anckarsater H, Råstam M, et al. Childhood attention-deficit hyperactivity disorder as an extreme of a continuous trait: a quantitative genetic study of 8,500 twin pairs. J Child Psychol Psychiatry. 2012;53(1):73–80.
  • Levy F, Hay DA, McStephen M, et al. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry. 1997;36(6):737–744.
  • Li T, Mota NR, Galesloot TE, et al. ADHD symptoms in the adult general population are associated with factors linked to ADHD in adult patients. Eur Neuropsychopharmacol. 2019;29(10):1117–1126.
  • Curry AE, Yerys BE, Metzger KB, et al. Traffic crashes, violations, and suspensions among young drivers with ADHD. Pediatrics. 2019;143(6):1–11.
  • Fuermaier AB, Tucha L, Evans BL, et al. Driving and attention deficit hyperactivity disorder. J Neural Transm (Vienna). 2017;124(Suppl 1):55–67.
  • Dalley JW, Roiser JP. Dopamine, serotonin and impulsivity. Neuroscience. 2012;215:42–58.
  • Ludolph AG, Kassubek J, Schmeck K, et al. Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F] fluorophenyl-l-alanine PET study. Neuroimage. 2008;41(3):718–727.
  • Thapar A, O’Donovan M, Owen MJ. The genetics of attention deficit hyperactivity disorder. Human Mol Gen. 2005;14(suppl_2):R275–R282.
  • Krause J, Dresel SH, Krause KH, et al. Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele. World J Biol Psychiatry. 2006;7(3):152–157.
  • Chen N, Reith ME. Structure and function of the dopamine transporter. Eur J Pharmacol. 2000;405(1-3):329–339.
  • Costa A, Riedel M, Müller U, et al. Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies. Synapse. 2011;65(10):998–1005.
  • Faraone SV, Spencer TJ, Madras BK, et al. Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a Meta-analysis. Mol Psychiatry. 2014;19(8):880–889.
  • Van de Giessen EM, de Win MM, Tanck MW, et al. Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med. 2009;50(1):45–52.
  • Franke B, Vasquez AA, Johansson S, et al. Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. Neuropsychopharmacol. 2010;35(3):656–664.
  • Franke B, Faraone SV, Asherson P, et al. The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol Psychiatry. 2012;17(10):960–987.
  • Tokko T, Eensoo D, Vaht M, et al. Relapse of drunk driving and association with traffic accidents, alcohol-related problems and biomarkers of impulsivity. Acta Neuropsychiatr. 2019;31(2):84–92.
  • Luht K, Tokko T, Eensoo D, et al. Efficacy of intervention at traffic schools reducing impulsive action, and association with candidate gene variants. Acta Neuropsychiatr. 2019;31(3):159–166.
  • Eensoo D, Paaver M, Vaht M, et al. Risky driving and the persistent effect of a randomized intervention focusing on impulsivity: the role of the serotonin transporter promoter polymorphism. Accid Anal Prev. 2018;113:19–24.
  • Paaver M, Eensoo D, Kaasik K, et al. Preventing risky driving: a novel and efficient brief intervention focusing on acknowledgement of personal risk factors. Accid Anal Prev. 2013;50:430–437.
  • Harro M, Eensoo D, Kiive E, et al. Platelet monoamine oxidase in healthy 9-and 15-years old children: the effect of gender, smoking and puberty. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25(8):1497–1511.
  • Joost U, Villa I, Comasco E, et al. Association between transcription factor AP-2B genotype, obesity, insulin resistance and dietary intake in a longitudinal birth cohort study. Int J Obes (Lond)). 2019;43(10):2095–2106.
  • Luht K, Eensoo D, Tooding LM, et al. The association of measures of the serotonin system, personality, alcohol use, and smoking with risk-taking traffic behavior in adolescents in a longitudinal study. Nordic J Psychiatry. 2018;72(1):9–16.
  • Tomson K, Merenäkk L, Loit HM, et al. The relationship between serotonin transporter gene promoter polymorphism and serum lipid levels at young age in a longitudinal population-representative study. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(8):1857–1862.
  • Kessler RC, Adler L, Ames M, et al. The world health organization adult ADHD Self-Report scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245–256.
  • Lawton R, Parker D, Stradling SG, et al. Self‐reported attitude towards speeding and its possible consequences in five different road contexts. J Community Appl Soc Psychol. 1997;7(2):153–165.
  • Reason J, Manstead A, Stradling S, et al. Errors and violations on the roads: a real distinction? Ergonomics. 1990;33(10-11):1315–1332.
  • De Winter JC, Dodou D. The driver behaviour questionnaire as a predictor of accidents: a Meta-analysis. J Safety Res. 2010;41(6):463–470.
  • Eensoo D, Paaver M, Tokko T, et al. 2020. Adaptation and validation of Driver Behaviour Questionnaire to Estonian and Russian. [Poster presentation]. Conference Vision Zero for Sustainable Road Safety in the Baltic Sea Region, 2–3.12.2020, Riga, Latvia.
  • Deffenbacher JL, Oetting ER, Lynch RS. Development of a driving anger scale. Psychol Rep. 1994;74(1):83–91.
  • Laas K, Reif A, Herterich S, et al. The effect of a functional NOS1 promoter polymorphism on impulsivity is moderated by platelet MAO activity. Psychopharmacol (Berl). 2010;209(3):255–261.
  • Dickman SJ. Functional and dysfunctional impulsivity: personality and cognitive correlates. J Pers Soc Psychol. 1990;58(1):95–102.
  • Anchordoquy HC, McGeary C, Liu L, et al. Genotyping of three candidate genes after whole-genome preamplification of DNA collected from buccal cells. Behav Genet. 2003;33(1):73–78.
  • Maksimov M, Vaht M, Murd C, et al. Brain dopaminergic system related genetic variability interacts with target/mask timing in metacontrast masking. Neuropsychologia. 2015;71:112–118.
  • Dresler T, Ehlis AC, Heinzel S, et al. Dopamine transporter (SLC6A3) genotype impacts neurophysiological correlates of cognitive response control in an adult sample of patients with ADHD. Neuropsychopharmacol. 2010;35(11):2193–2202.
  • Bertolino A, Blasi G, Latorre V, et al. Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. J Neurosci. 2006;26(15):3918–3922.
  • Mattay VS, Tessitore A, Callicott JH, et al. Dopaminergic modulation of cortical function in patients with Parkinson’s disease. Ann Neurol. 2002;51(2):156–164.
  • Newman J, Grace AA. Binding across time: the selective gating of frontal and hippocampal systems modulating working memory and attentional states. Conscious Cognit. 1999;8(2):196–212.
  • Bédard AC, Schulz KP, Cook EH, Jr, et al. Dopamine transporter gene variation modulates activation of striatum in youth with ADHD. Neuroimage. 2010;53(3):935–942.
  • Brown BK, Murrell J, Karne H, et al. The effects of DAT1 genotype on fMRI activation in an emotional go/no-go task. Brain Imaging Behav. 2017;11(1):185–193.
  • Fabiano GA, Schatz NK, Hulme KF, et al. Positive bias in teenage drivers with ADHD within a simulated driving task. J Atten Disord. 2018;22(12):1150–1157.
  • Chang Z, Lichtenstein P, D’Onofrio BM, et al. Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. JAMA Psychiatry. 2014;71(3):319–325.
  • Montag C, Panksepp J. Primary emotional systems and personality: an evolutionary perspective. Front Psychol. 2017;8:464.
  • Panksepp J. Affective neuroscience: the foundations of human and animal emotions. UK: Oxford University Press; 1998.
  • Fayyad J, Sampson NA, Hwang I, et al. The descriptive epidemiology of DSM-IV adult ADHD in the world health organization world mental health surveys. Atten Defic Hyperact Disord. 2017;9(1):47–65.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.